2024-04-30 |
2024-04-29 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
1,000
-3.3%
375.39
100,000
USD
|
1,000
-3.3%
|
375.39
|
100,000
USD
|
|
2024-04-30 |
2024-04-29 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
1,000
-3.3%
375.39
100,000
USD
|
1,000
-3.3%
|
375.39
|
100,000
USD
|
|
2024-04-30 |
2024-04-26 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
1,000
-3.3%
368.10
100,000
USD
|
1,000
-3.3%
|
368.10
|
100,000
USD
|
|
2024-04-30 |
2024-04-26 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
1,000
-2.1%
368.10
100,000
USD
|
1,000
-2.1%
|
368.10
|
100,000
USD
|
|
2024-04-30 |
2024-04-26 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
1,000
-2.1%
368.10
100,000
USD
|
1,000
-2.1%
|
368.10
|
100,000
USD
|
|
2024-04-30 |
2024-04-26 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
1,000
-1.6%
368.10
100,000
USD
|
1,000
-1.6%
|
368.10
|
100,000
USD
|
|
2024-04-30 |
2024-04-26 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
1,000
-6.7%
368.10
100,000
USD
|
1,000
-6.7%
|
368.10
|
100,000
USD
|
|
2024-04-30 |
2024-04-26 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
1,000
-6.7%
375.00
100,000
USD
|
1,000
-6.7%
|
375.00
|
100,000
USD
|
|
2024-04-30 |
2024-04-26 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
1,000
-3.3%
368.10
100,000
USD
|
1,000
-3.3%
|
368.10
|
100,000
USD
|
|
2024-04-24 |
2024-04-23 |
PS
Planned sale
|
Curet Myriam
EVP & Chief Medical Officer
Officer
|
1,000
-89.3%
370.66
100,000
USD
|
1,000
-89.3%
|
370.66
|
100,000
USD
|
|
2024-04-24 |
2024-04-23 |
PS
Planned sale
|
Curet Myriam
EVP & Chief Medical Officer
Officer
|
1,000
-90.4%
370.66
100,000
USD
|
1,000
-90.4%
|
370.66
|
100,000
USD
|
|
2024-04-24 |
2024-04-23 |
PS
Planned sale
|
LEVY ALAN J
Non-Executive Director
|
1,000
-7.3%
370.70
100,000
USD
|
1,000
-7.3%
|
370.70
|
100,000
USD
|
|
2024-03-18 |
2024-03-15 |
PS
Planned sale
|
Widman Fredrik
VP Corporate Controller
Officer
|
612
-84.8%
397.07
243,007
USD
|
612
-84.8%
|
397.07
|
243,007
USD
|
|
2024-03-18 |
2024-03-15 |
PS
Planned sale
|
Widman Fredrik
VP Corporate Controller
Officer
|
612
-84.8%
397.07
243,007
USD
|
612
-84.8%
|
397.07
|
243,007
USD
|
|
2024-03-18 |
2024-03-15 |
PS
Planned sale
|
Widman Fredrik
VP Corporate Controller
Officer
|
3,817
-97.2%
397.07
1,515,616
USD
|
3,817
-97.2%
|
397.07
|
1,515,616
USD
|
|
2024-03-11 |
2024-03-11 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
120
-2.1%
390.16
46,819
USD
|
120
-2.1%
|
390.16
|
46,819
USD
|
|
2024-03-11 |
2024-03-11 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
119
-2.1%
390.16
46,429
USD
|
119
-2.1%
|
390.16
|
46,429
USD
|
|
2024-03-11 |
2024-03-11 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
90
-1.6%
390.16
35,114
USD
|
90
-1.6%
|
390.16
|
35,114
USD
|
|
2024-03-11 |
2024-03-11 |
PS
Planned sale
|
Brosius Mark
SVP & Chief Mfg and Supply Cha
Officer
|
196
-15.6%
390.16
76,471
USD
|
196
-15.6%
|
390.16
|
76,471
USD
|
|
2024-03-11 |
2024-03-08 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
2,749
-33.3%
393.83
1,082,641
USD
|
2,749
-33.3%
|
393.83
|
1,082,641
USD
|
|
2024-03-11 |
2024-03-08 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
2,819
-25.5%
393.79
1,110,106
USD
|
2,819
-25.5%
|
393.79
|
1,110,106
USD
|
|
2024-03-11 |
2024-03-08 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
940
-7.8%
393.82
370,187
USD
|
940
-7.8%
|
393.82
|
370,187
USD
|
|
2024-03-11 |
2024-03-08 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
1,436
-11.5%
393.82
565,520
USD
|
1,436
-11.5%
|
393.82
|
565,520
USD
|
|
2024-03-11 |
2024-03-08 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
1,437
-11.5%
393.80
565,893
USD
|
1,437
-11.5%
|
393.80
|
565,893
USD
|
|
2024-03-11 |
2024-03-08 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
453
-3.9%
393.80
178,390
USD
|
453
-3.9%
|
393.80
|
178,390
USD
|
|
2024-03-11 |
2024-03-08 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
363
-3.2%
393.80
142,948
USD
|
363
-3.2%
|
393.80
|
142,948
USD
|
|
2024-03-11 |
2024-03-08 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
453
-3.9%
393.80
178,393
USD
|
453
-3.9%
|
393.80
|
178,393
USD
|
|
2024-03-11 |
2024-03-08 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
993
-8.2%
393.80
391,046
USD
|
993
-8.2%
|
393.80
|
391,046
USD
|
|
2024-03-11 |
2024-03-08 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
7,149
-39.2%
393.78
2,815,097
USD
|
7,149
-39.2%
|
393.78
|
2,815,097
USD
|
|
2024-03-11 |
2024-03-08 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
1,504
-12.0%
393.81
592,287
USD
|
1,504
-12.0%
|
393.81
|
592,287
USD
|
|
2024-03-11 |
2024-03-08 |
PS
Planned sale
|
Brosius Mark
SVP & Chief Mfg and Supply Cha
Officer
|
196
-13.5%
392.02
76,836
USD
|
196
-13.5%
|
392.02
|
76,836
USD
|
|
2024-03-07 |
2024-03-07 |
PS
Planned sale
|
Brosius Mark
SVP & Chief Mfg and Supply Cha
Officer
|
196
-11.9%
393.30
77,087
USD
|
196
-11.9%
|
393.30
|
77,087
USD
|
|
2024-03-07 |
2024-03-06 |
PS
Planned sale
|
Brosius Mark
SVP & Chief Mfg and Supply Cha
Officer
|
196
-10.6%
386.76
75,805
USD
|
196
-10.6%
|
386.76
|
75,805
USD
|
|
2024-03-07 |
2024-03-05 |
PS
Planned sale
|
Brosius Mark
SVP & Chief Mfg and Supply Cha
Officer
|
196
-9.6%
400.00
78,400
USD
|
196
-9.6%
|
400.00
|
78,400
USD
|
|
2024-03-01 |
2024-03-01 |
PS
Planned sale
|
Curet Myriam
EVP & Chief Medical Officer
Officer
|
1,605
-84.3%
383.48
615,485
USD
|
1,605
-84.3%
|
383.48
|
615,485
USD
|
|
2024-02-29 |
2024-02-28 |
PS
Planned sale
|
MOHR MARSHALL
Executive VP Global Business S
Officer
|
10,500
-18.0%
385.08
4,043,345
USD
|
10,500
-18.0%
|
385.08
|
4,043,345
USD
|
|
2024-02-29 |
2024-02-28 |
PS
Planned sale
|
MOHR MARSHALL
Executive VP Global Business S
Officer
|
6,860
-12.5%
385.08
2,641,659
USD
|
6,860
-12.5%
|
385.08
|
2,641,659
USD
|
|
2024-02-29 |
2024-02-28 |
PS
Planned sale
|
MOHR MARSHALL
Executive VP Global Business S
Officer
|
13,750
-24.0%
385.08
5,294,842
USD
|
13,750
-24.0%
|
385.08
|
5,294,842
USD
|
|
2024-02-29 |
2024-02-28 |
PS
Planned sale
|
MOHR MARSHALL
Executive VP Global Business S
Officer
|
14,620
-29.6%
385.09
5,630,044
USD
|
14,620
-29.6%
|
385.09
|
5,630,044
USD
|
|
2024-02-29 |
2024-02-28 |
PS
Planned sale
|
MOHR MARSHALL
Executive VP Global Business S
Officer
|
12,750
-32.2%
385.08
4,909,776
USD
|
12,750
-32.2%
|
385.08
|
4,909,776
USD
|
|
2024-02-29 |
2024-02-28 |
PS
Planned sale
|
MOHR MARSHALL
Executive VP Global Business S
Officer
|
12,750
-32.2%
385.08
4,909,776
USD
|
12,750
-32.2%
|
385.08
|
4,909,776
USD
|
|
2024-02-29 |
2024-02-28 |
PS
Planned sale
|
MOHR MARSHALL
Executive VP Global Business S
Officer
|
10,500
-28.1%
385.08
4,043,345
USD
|
10,500
-28.1%
|
385.08
|
4,043,345
USD
|
|
2024-02-29 |
2024-02-28 |
PS
Planned sale
|
MOHR MARSHALL
Executive VP Global Business S
Officer
|
13,530
-33.5%
385.08
5,210,139
USD
|
13,530
-33.5%
|
385.08
|
5,210,139
USD
|
|
2024-02-29 |
2024-02-28 |
PS
Planned sale
|
MOHR MARSHALL
Executive VP Global Business S
Officer
|
13,530
-33.5%
385.08
5,210,139
USD
|
13,530
-33.5%
|
385.08
|
5,210,139
USD
|
|
2024-02-27 |
2024-02-27 |
PS
Planned sale
|
Curet Myriam
EVP & Chief Medical Officer
Officer
|
843
-73.9%
386.46
325,786
USD
|
843
-73.9%
|
386.46
|
325,786
USD
|
|
2024-02-16 |
2024-02-16 |
PS
Planned sale
|
Brosius Mark
SVP & Chief Mfg and Supply Cha
Officer
|
32
-4.3%
378.29
12,105
USD
|
32
-4.3%
|
378.29
|
12,105
USD
|
|
2024-02-16 |
2024-02-15 |
PS
Planned sale
|
Brosius Mark
SVP & Chief Mfg and Supply Cha
Officer
|
30
-3.9%
382.03
11,461
USD
|
30
-3.9%
|
382.03
|
11,461
USD
|
|
2024-02-16 |
2024-02-14 |
PS
Planned sale
|
Brosius Mark
SVP & Chief Mfg and Supply Cha
Officer
|
30
-3.7%
380.09
11,403
USD
|
30
-3.7%
|
380.09
|
11,403
USD
|
|
2024-02-13 |
2024-02-13 |
PS
Planned sale
|
Brosius Mark
SVP & Chief Mfg and Supply Cha
Officer
|
30
-3.6%
375.51
11,265
USD
|
30
-3.6%
|
375.51
|
11,265
USD
|
|
2024-02-13 |
2024-02-12 |
PS
Planned sale
|
Brosius Mark
SVP & Chief Mfg and Supply Cha
Officer
|
30
-3.5%
386.09
11,583
USD
|
30
-3.5%
|
386.09
|
11,583
USD
|
|
2024-02-13 |
2024-02-12 |
PS
Planned sale
|
Curet Myriam
EVP & Chief Medical Officer
Officer
|
481
-61.7%
386.09
185,709
USD
|
481
-61.7%
|
386.09
|
185,709
USD
|
|
2024-02-08 |
2024-02-07 |
PS
Planned sale
|
Rosa David J.
President
Officer
|
15,700
-6.8%
389.29
6,111,784
USD
|
15,700
-6.8%
|
389.29
|
6,111,784
USD
|
|
2024-02-08 |
2024-02-07 |
PS
Planned sale
|
Rosa David J.
President
Officer
|
23,120
-10.3%
389.28
9,000,195
USD
|
23,120
-10.3%
|
389.28
|
9,000,195
USD
|
|
2024-02-08 |
2024-02-07 |
PS
Planned sale
|
Rosa David J.
President
Officer
|
16,150
-8.0%
389.23
6,286,026
USD
|
16,150
-8.0%
|
389.23
|
6,286,026
USD
|
|
2024-02-08 |
2024-02-07 |
PS
Planned sale
|
Rosa David J.
President
Officer
|
12,840
-6.9%
389.30
4,998,665
USD
|
12,840
-6.9%
|
389.30
|
4,998,665
USD
|
|
2024-02-08 |
2024-02-07 |
PS
Planned sale
|
Rosa David J.
President
Officer
|
12,900
-7.3%
389.29
5,021,798
USD
|
12,900
-7.3%
|
389.29
|
5,021,798
USD
|
|
2024-02-05 |
2024-02-01 |
PS
Planned sale
|
Brosius Mark
SVP & Chief Mfg and Supply Cha
Officer
|
39
-8.0%
378.41
14,758
USD
|
39
-8.0%
|
378.41
|
14,758
USD
|
|
2024-01-30 |
2024-01-29 |
PS
Planned sale
|
GUTHART GARY S
CEO
Executive Director
|
2,480
-8.3%
374.41
928,537
USD
|
2,480
-8.3%
|
374.41
|
928,537
USD
|
|
2024-01-30 |
2024-01-29 |
PS
Planned sale
|
GUTHART GARY S
CEO
Executive Director
|
2,480
-8.3%
374.41
928,537
USD
|
2,480
-8.3%
|
374.41
|
928,537
USD
|
|
2024-01-30 |
2024-01-29 |
PS
Planned sale
|
GUTHART GARY S
CEO
Executive Director
|
24,325
-72.1%
376.06
9,147,669
USD
|
24,325
-72.1%
|
376.06
|
9,147,669
USD
|
|
2024-01-29 |
2024-01-26 |
S
Sale
|
LEVY ALAN J
Non-Executive Director
|
1,928
-7.1%
370.20
713,750
USD
|
1,928
-7.1%
|
370.20
|
713,750
USD
|
|
2024-01-29 |
2024-01-26 |
PS
Planned sale
|
LEVY ALAN J
Non-Executive Director
|
72
-0.3%
370.20
26,655
USD
|
72
-0.3%
|
370.20
|
26,655
USD
|
|
2024-01-29 |
2024-01-26 |
PS
Planned sale
|
Curet Myriam
EVP & Chief Medical Officer
Officer
|
1,500
-88.8%
370.15
555,222
USD
|
1,500
-88.8%
|
370.15
|
555,222
USD
|
|
2024-01-29 |
2024-01-26 |
PS
Planned sale
|
Curet Myriam
EVP & Chief Medical Officer
Officer
|
2,818
-93.7%
370.15
1,043,077
USD
|
2,818
-93.7%
|
370.15
|
1,043,077
USD
|
|
2024-01-29 |
2024-01-26 |
PS
Planned sale
|
Johnson Amal M
Non-Executive Director
|
6,696
-36.4%
370.08
2,478,032
USD
|
6,696
-36.4%
|
370.08
|
2,478,032
USD
|
|
2023-11-17 |
2023-11-16 |
PS
Planned sale
|
Curet Myriam
EVP & Chief Medical Officer
Officer
|
1,500
-88.8%
300.00
450,000
USD
|
1,500
-88.8%
|
300.00
|
450,000
USD
|
|
2023-11-17 |
2023-11-16 |
PS
Planned sale
|
Curet Myriam
EVP & Chief Medical Officer
Officer
|
4,500
-96.0%
300.00
1,350,000
USD
|
4,500
-96.0%
|
300.00
|
1,350,000
USD
|
|
2023-11-17 |
2023-11-16 |
PS
Planned sale
|
Curet Myriam
EVP & Chief Medical Officer
Officer
|
2,819
-93.7%
300.00
845,700
USD
|
2,819
-93.7%
|
300.00
|
845,700
USD
|
|
2023-11-17 |
2023-11-16 |
PS
Planned sale
|
Johnson Amal M
Non-Executive Director
|
9,567
-45.0%
300.00
2,870,100
USD
|
9,567
-45.0%
|
300.00
|
2,870,100
USD
|
|
2023-11-15 |
2023-11-14 |
PS
Planned sale
|
LEVY ALAN J
Non-Executive Director
|
2,000
-7.3%
290.00
580,000
USD
|
2,000
-7.3%
|
290.00
|
580,000
USD
|
|
2023-11-15 |
2023-11-14 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
270
-3.6%
290.00
78,300
USD
|
270
-3.6%
|
290.00
|
78,300
USD
|
|
2023-11-15 |
2023-11-14 |
PS
Planned sale
|
DeSantis Robert
EVP & Chief Strategy & Corp Op
Officer
|
597
-7.6%
290.00
173,130
USD
|
597
-7.6%
|
290.00
|
173,130
USD
|
|
2023-10-26 |
2023-10-26 |
PS
Planned sale
|
GUTHART GARY S
CEO
Executive Director
|
27,385
-53.8%
260.11
7,123,030
USD
|
27,385
-53.8%
|
260.11
|
7,123,030
USD
|
|
2023-10-26 |
2023-10-24 |
PS
Planned sale
|
GUTHART GARY S
CEO
Executive Director
|
2,480
-7.7%
271.93
674,386
USD
|
2,480
-7.7%
|
271.93
|
674,386
USD
|
|
2023-10-26 |
2023-10-24 |
PS
Planned sale
|
GUTHART GARY S
CEO
Executive Director
|
2,480
-7.7%
271.93
674,386
USD
|
2,480
-7.7%
|
271.93
|
674,386
USD
|
|